Expenditures on Screening Promotion Activities in CDC’s Colorectal Cancer Control Program, 2009–2014
ORIGINAL RESEARCH — Volume 16 — May 23, 2019
PEER REVIEWED
Figure 1.
Average cost per grantee for each screening promotion activity, by year, Colorectal Cancer Control Program, 2009–2014. Error bars represent 95% confidence intervals.
| Category | Year 1 (95% CI) | Year 2 (95% CI) | Year 3 (95% CI) | Year 4 (95% CI) | Year 5 (95% CI) |
|---|---|---|---|---|---|
| Client reminders | 13,357 (0–28,963) | 23,350 (638–46,062) | 15,520 (1,633–29,407) | 10,175 (3,094–17,257) | 6,241 (2,814–9,668) |
| Small media | 71,769 (35,098–108,440) | 43,978 (18,848–69,107) | 31,661 (16,998–46,324) | 34,012 (17,828–50,197) | 40,191 (8,683–71,700) |
| Mass media | 79,962 (27,077–132,847) | 104,351 (36,539–172,163) | 91,825 (40,600–143,049) | 83,375 (25,632–141,119) | 65,453 (16,388–114,517) |
| Outreach and education | 30,062 (0–67,058) | 20,521 (0–47,606) | 31,941 (7,181–56,701) | 49,662 (15,795–83,530) | 41,300 (18,195–64,406) |
| Provider assessments and reminders | 25,502 (7,201–43,802) | 28,301 (2,401–54,200) | 28,710 (2,889–54,532) | 31,355 (5,263–57,447) | 32,909 (7,857–57,962) |
| Patient navigation | 61,364 (1,491–121,237) | 38,185 (10,720–65,650) | 45,123 (11,936–78,310) | 55,451 (20,550–90,351) | 59,731 (19,114–100,348) |
| Other promotion activities | 33,812 (15,786–51,838) | 59,243 (18,970–99,516) | 48,669 (9,045–88,294) | 25,720 (10,740–40,699) | 40,964 (19,950–61,978) |
Figure 2.
Average cost, in dollars, for each screening promotion activity (5-year period), by screening rates and by eligible population size, Colorectal Cancer Control Program, 2009–2014. Error bars represent 95% confidence intervals. State-level screening rates (panel A) were classified as high (screening rates ranging from 69.6 to 76.6 [>66th percentile]), medium (screening rates ranging from 65.9 to 69.5 [34th to 66th percentile]), or low (screening rates ranging from 56.5 to 65.8 [<34th percentile]). Grantee populations eligible for screening (panel B) were analyzed based on percentiles (small, <34th; medium, 34th–66th; large, >66th percentile) for those eligible but not screened.
| Category | High (95% CI) | Medium (95% CI) | Low (95% CI) |
|---|---|---|---|
| By screening rates | |||
| Client reminders | 15,282 (3,236–27,328) | 21,006 (6,502–35,509) | 5,874 (3,283–8,465) |
| Small media | 37,430 (25,826–49,033) | 32,167 (13,519–50,814) | 59,066 (34,931–83,202) |
| Mass media | 74,774 (40,957–108,591) | 128,527 (69,446–187,608) | 56,357 (28,175–84,538) |
| Outreach and education | 13,010 (379–25,641) | 58,501 (28,241–88,760) | 34,001 (15,170–52,832) |
| Provider assessments and reminders | 18,362 (9,859–26,864) | 59,854 (31,088–88,620) | 13,047 (3,774–22,320) |
| Patient navigation | 111,764 (69,905–153,623) | 32,746 (10,348–55,144) | 15,248 (7,143–23,352) |
| Other promotion activities | 28,798 (13,702–43,893) | 54,679 (23,508–85,851) | 42,013 (24,226–59,801) |
| Category | Large (95% CI) | Medium (95% CI) | Small (95% CI) |
|---|---|---|---|
| By eligible population size | |||
| Client reminders | 21,420 (8,315–34,526) | 12,735 (0–26,310) | 6,984 (4,750–9,218) |
| Small media | 24,876 (13,895–35,857) | 58,954 (33,449–84,459) | 49,383 (29,017–69,748) |
| Mass media | 76,240 (32,978–119,503) | 93,311 (53,259–133,362) | 86,635 (44,334–128,936) |
| Outreach and education | 58,944 (31,490–86,398) | 37,580 (12,929–62,232) | 9,898 (1,768–18,029) |
| Provider assessments and reminders | 46,206 (22,771–69,642) | 28,343 (7,886–48,799) | 14,363 (6,747–21,978) |
| Patient navigation | 42,163 (21,532–62,793) | 50,949 (20,487–81,411) | 61,818 (26,103–97,533) |
| Other promotion activities | 62,432 (32,371–92,494) | 21,822 (11,060–32,584) | 37,809 (21,235–54,383) |
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.